Capstone Capital Management »

Summit Therapeutics shares owned by Capstone Capital Management

Quarter-by-quarter ownership of Summit Therapeutics (SMMT) shares owned by Capstone Capital Management from 13F filings

Historical chart of Capstone Capital Management investment in Summit Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Summit Therapeutics held by Capstone Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Summit Therapeutics by Capstone Capital Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $493k 28k 17.49

More positions owned by Capstone Capital Management

Intel Corporation (INTC)
Ishares Tr Core Us Aggbd Et (AGG)
Synopsys (SNPS)
Select Sector Spdr Tr State Street Con (XLP)
NVIDIA Corporation (NVDA)
Boeing Company (BA)
Ishares Tr Msci Eafe Etf (EFA)
Pdd Holdings Sponsored Ads (PDD)
Select Sector Spdr Tr State Street Ene (XLE)
Select Sector Spdr Tr State Street Hea (XLV)
Barclays Bank Ipath S&p 500 Sh (VXX)
Oracle Corporation (ORCL)
Arista Networks Com Shs (ANET)
Taiwan Semiconductor Mfg Sponsored Ads (TSM)
Proshares Tr Ultrapro Sht Qqq

View all positions for Capstone Capital Management

Top funds holding Summit Therapeutics

Baker Bros. Advisors
Vanguard Group
FMR
BlackRock
State Street Corporation
Susquehanna International
Geode Capital Management
Citadel Advisors
Pictet Asset Management Holding SA
Norges Bank Investment Management
Apeiron Capital
Nomura Holdings
TD Asset Management
Standard Life Aberdeen
Charles Schwab Investment Management

View all funds holding Summit Therapeutics